Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
13
NCT03092934
A Study of AK-01 (LY3295668) in Solid Tumors
Phase: Phase 1/2
Role: Collaborator
Start: May 29, 2017
Completion: Apr 20, 2020